Skip to Content

News Releases

Dec 02 2021
SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions
BOULDER, Colo., Dec. 02, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions (M&A).
Nov 15 2021
SomaLogic Reports Third Quarter 2021 Financial Results
Increase of 40% in third quarter revenue to $20.0 million over the corresponding period in 2020 Increase of 112% in year-to-date revenue to $58.6 million over the corresponding period in 2020 Raising 2021 full year revenue guidance to $77-79 million Addition of 61 new customer accounts expands and
Nov 03 2021
SomaLogic to Present at the Stifel 2021 Virtual Healthcare Conference
NEW YORK and BOULDER, Colo., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Stifel 2021 Virtual Healthcare Conference. SomaLogic’s management is scheduled to participate in a
Nov 01 2021
SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease
BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospitals Cleveland Medical Center, where they will evaluate the
Oct 28 2021
SomaLogic to Announce Third Quarter 2021 Financial Results
BOULDER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the third quarter 2021 before the market opens on Monday, November 15, 2021.
Oct 20 2021
A new study using the SomaScan® Platform makes the connection between genes and proteins and their impact on human disease
BOULDER, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- In the largest proteogenomic study of its kind to date, an international research team led by scientists at the Berlin Institute of Health at Charité and the University of Cambridge used SomaLogic’s (NASDAQ: SLGC) SomaScan ® Platform to generate
Sep 22 2021
SomaLogic Announces Upcoming Conference Participation and Analyst Meeting
NEW YORK and BOULDER, Colo., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today is announcing upcoming conference participation in addition to its analyst meeting. Event Details : SomaLogic Analyst Meeting Format: Virtual event for the
Sep 13 2021
SomaLogic announces strategic collaboration with UPMC to tailor clinical care through proteomics technology
BOULDER, Colo., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with leading health system UPMC to explore how the large-scale study of proteins and their functions in the body can effectively be
Sep 08 2021
SomaLogic Reports First Half of 2021 Financial Results
NEW YORK and BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the six months ended June 30, 2021. “Our strong first half performance reflects our team’s dedication and execution across key
Sep 07 2021
SomaLogic to Present at Morgan Stanley 19th Annual Global Healthcare Conference
NEW YORK and BOULDER, Colo., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference.
Displaying 1 - 10 of 29